Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.
作者信息
Murphy Tracy, Zou Jinfeng, Arruda Andrea, Wang Ting Ting, Zhao Zhen, Zheng Yangqiao, Gupta Vikas, Maze Dawn, McNamara Caroline, Minden Mark D, Schimmer Aaron, Sibai Hassan, Yee Karen, Capo-Chichi Jose-Mario, Stockley Tracy, Schuh Andre, Bratman Scott V, Chan Steven M
机构信息
Princess Margaret Cancer Center, University Health Network, Toronto, Ontario.
Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
出版信息
Haematologica. 2024 Feb 1;109(2):671-675. doi: 10.3324/haematol.2023.283510.
Abstract
摘要
Zotero 插件